✦ LIBER ✦

Medication Utilization Behavior in Patients Receiving Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction

✍ Scribed by John P. Mulhall; Trent P. McLaughlin; James P. Harnett; Brian Scott; Soraya Burhani; David Russell

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical update on phosphodiesterase typ

✍ Alberto Briganti; Andrea Salonia; Federico Deho’; Giuseppe Zanni; Luigi Barbieri 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 278 KB

Phosphodiesterase type 5 (PDE5) inhibito

✍ Dorsey, Philip; Keel, Christopher; Klavens, Meghan; Hellstrom, Wayne JG 📂 Article 📅 2010 🏛 Informa plc 🌐 English ⚖ 298 KB

Phosphodiesterase type 5 inhibitors for

✍ Vickers, M A; Satyanarayana, R 📂 Article 📅 2002 🏛 Nature Publishing Group 🌐 English ⚖ 97 KB

Phosphodiesterase Type 5 (PDE5) Inhibito

✍ Giovanni Corona; Nicola Mondaini; Andrea Ungar; Elisa Razzoli; Andrea Rossi; Fer 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 613 KB

Erectile dysfunction and cardiovascular

✍ Adolph M. Hutter Jr. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 13 KB

Phosphodiesterase Type 5 Inhibitor and E

✍ Chen ZHAO; Jong KWAN PARK 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 537 KB